DXA scanning and its interpretation in osteoporosis

被引：17

作者：

Blake, GM ^{[1
]}

Fogelman, I ^{[1
]}

机构：

[1] Guys Hosp, Dept Nucl Med, London SE1 9RT, England

来源：

HOSPITAL MEDICINE | 2003年 / 64卷 / 09期

关键词：

D O I：

10.12968/hosp.2003.64.9.2243

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The recent growth in the clinical use of bone densitometry began with the introduction of the first dual X-ray absorptiometry (DXA) scanning systems in the late 1980s. Today, scans to measure bone mineral density are seen as having an essential role in the evaluation of patients at risk of osteoporosis.

引用

页码：521 / 525

页数：5

共 18 条

[1] Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].

Black, DM ;

Cummings, SR ;

Karpf, DB ;

Cauley, JA ;

Thompson, DE ;

Nevitt, MC ;

Bauer, DC ;

Genant, HK ;

Haskell, WL ;

Marcus, R ;

Ott, SM ;

Torner, JC ;

Quandt, SA ;

Reiss, TF ;

Ensrud, KE .

LANCET, 1996, 348 (9041) :1535-1541

[2] Forearm bone mineral densitometry cannot be used to monitor response to alendronate therapy in postmenopausal women [J].

Bouxsein, ML ;

Parker, RA ;

Greenspan, SL .

OSTEOPOROSIS INTERNATIONAL, 1999, 10 (06) :505-509

[3] HIP-FRACTURES IN THE ELDERLY - A WORLDWIDE PROJECTION [J].

COOPER, C ;

CAMPION, G ;

MELTON, LJ .

OSTEOPOROSIS INTERNATIONAL, 1992, 2 (06) :285-289

[4] Treatment of postmenopausal osteoporosis [J].

Eastell, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (11) :736-746

[5] Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial [J].

Ettinger, B ;

Black, DM ;

Mitlak, BH ;

Knickerbocker, RK ;

Nickelsen, T ;

Genant, HK ;

Christiansen, C ;

Delmas, PD ;

Zanchetta, JR ;

Stakkestad, J ;

Glüer, CC ;

Krueger, K ;

Cohen, FJ ;

Eckert, S ;

Ensrud, KE ;

Avioli, LV ;

Lips, P ;

Cummings, SR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :637-645

[6] Discordance in patient classification using T-scores [J].

Faulkner, KG ;

von Stetten, E ;

Miller, P .

JOURNAL OF CLINICAL DENSITOMETRY, 1999, 2 (03) :343-350

[7]

Genant HK, 1996, J BONE MINER RES, V11, P707

[8] Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis - A randomized controlled trial [J].

Harris, ST ;

Watts, NB ;

Genant, HK ;

McKeever, CD ;

Hangartner, T ;

Keller, M ;

Chesnut, CH ;

Brown, J ;

Eriksen, EF ;

Hoseyni, MS ;

Axelrod, DW ;

Miller, PD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (14) :1344-1352

[9] Peak bone mass [J].

Heaney, RP ;

Abrams, S ;

Dawson-Hughes, B ;

Looker, A ;

Marcus, R ;

Matkovic, V ;

Weaver, C .

OSTEOPOROSIS INTERNATIONAL, 2000, 11 (12) :985-1009

[10] Guidelines for diagnosis and management of osteoporosis [J].

Kanis, JA ;

Delmas, P ;

Burckhardt, P ;

Cooper, C ;

Torgerson, D .

OSTEOPOROSIS INTERNATIONAL, 1997, 7 (04) :390-406

← 1 2 →